Encrantz Staffan

Average Profitability
<0.0001%
Insider Buys Quantity
16
Insider Buys Sum
$29.07M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Encrantz Staffan

According to the SEC Form 4 filings, Encrantz Staffan, being in a position of

  1. at Sight Sciences, Inc.,
    оver the last 12 months, has bought 985116 shares for $2.99M, and sold 0 shares,
    over all time since 2021-10-18, has bought 2337164 shares for $29.07M, and sold 0 shares.

The largest purchase of all time was on 2021-10-18 and amounted to 527048 shares of Sight Sciences, Inc. for $12.65M.

Biography of Encrantz Staffan

No biography is available at this moment.

2023-11-30PurchaseSight Sciences, Inc.
SGHT
140,777
0.291%
$3.46$486,638+58.56%
2023-11-29PurchaseSight Sciences, Inc.
SGHT
3,223
0.0063%
$3.50$11,281+49.32%
2023-11-28PurchaseSight Sciences, Inc.
SGHT
253,669
0.5141%
$3.46$877,137+61.29%
2023-11-27PurchaseSight Sciences, Inc.
SGHT
246,331
0.4996%
$3.31$815,947+63.88%
2023-11-24PurchaseSight Sciences, Inc.
SGHT
21,855
0.0446%
$3.09$67,427+76.61%
2023-11-22PurchaseSight Sciences, Inc.
SGHT
41,085
0.0844%
$2.50$102,708+117.53%
2023-11-21PurchaseSight Sciences, Inc.
SGHT
68,477
0.1388%
$2.48$169,535+117.76%
2023-11-20PurchaseSight Sciences, Inc.
SGHT
79,234
0.1617%
$2.25$178,189+140.62%
2023-11-17PurchaseSight Sciences, Inc.
SGHT
126,664
0.2519%
$2.19$277,293+140.93%
2023-11-16PurchaseSight Sciences, Inc.
SGHT
339
0.0007%
$2.00$678+165.37%
2023-11-14PurchaseSight Sciences, Inc.
SGHT
3,462
0.0069%
$2.00$6,914+162.47%
2022-05-13PurchaseSight Sciences, Inc.
SGHT
300,000
0.6297%
$8.20$2.46M+17.83%
2021-12-01PurchaseSight Sciences, Inc.
SGHT
director
214,606
0.5032%
$22.40$4.81M-51.61%
2021-11-30PurchaseSight Sciences, Inc.
SGHT
director
223,940
0.4563%
$20.23$4.53M-53.44%
2021-11-29PurchaseSight Sciences, Inc.
SGHT
director
86,454
0.1823%
$18.85$1.63M-48.28%
2021-10-18PurchaseSight Sciences, Inc.
SGHT
director
527,048
1.2077%
$24.00$12.65M-53.08%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.